SCHEMBL7963975

SCHEMBL7963975

FC(F)(F)c1ccc(Cl)c(C2=CCN(CCCc3nnc4n3CCCCC4)CC2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.39
LMNA P02545 3/20 0.39
SHMT2 P34897 1/20 0.39
GAA P10253 2/20 0.38
HPGD P15428 4/20 0.38
PARP1 P09874 1/20 0.37
HSD11B1 P28845 1/20 0.37
ALDH1A1 P00352 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
POLB P06746 2/20 0.35
CHRM2 P08172 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA1D P25100 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
SLC6A4 P31645 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7961207 0.84 POLB (0.44) L3MBTL1LMNASHMT2GAAPARP1
SCHEMBL7960974 0.81 LMNA (0.45) LMNASHMT2GAAHPGDPARP1
SCHEMBL7959347 0.81 LMNA (0.45) LMNASHMT2GAAHPGDPARP1
SCHEMBL7959202 0.81 GAA (0.41) L3MBTL1LMNASHMT2GAAHPGD
SCHEMBL7949425 0.79 LMNA (0.52) LMNASHMT2GAAHPGDPARP1
SCHEMBL7958937 0.79 PKM (0.52) L3MBTL1LMNASHMT2GAAHPGD
SCHEMBL7949039 0.79 SIGMAR1 (0.53) GAAHPGDPARP1SMN1; SMN2HTR1A
SCHEMBL7959113 0.79 L3MBTL1 (0.41) L3MBTL1LMNASHMT2GAAHPGD
SCHEMBL7957285 0.77 SIGMAR1 (0.53) LMNAPARP1MEN1KMT2APOLB
SCHEMBL7963703 0.77 HSD11B1 (0.41) L3MBTL1LMNASHMT2GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed